← Leaderboards
Christina Yoon
University Of California, San Francisco
$3,572,200
Attributed
$7,584,848
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,584,848 · 6
By mechanism
R33$3,789,374 · 1
R61$2,229,598 · 2
K23$943,228 · 1
R21$386,710 · 1
R34$235,938 · 1
Top collaborators
- Patrick Pj Phillips7 shared
- David Wesley Dowdy5 shared
- Annettee Olivia Nakimuli2 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Adithya Cattamanchi$24,815,234
- Payam Nahid$19,473,523
- Claudia Maria Denkinger$8,036,745
- Janet M Turan$11,052,610
- Stephanie Correa$4,357,104
Others in their field
Top investigators on “Point Of Care”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- David Heimbrook · Leidos Biomedical Research, Inc.$122,677,088
- Judith S Hochman · New York University School Of Medicine$101,773,796
- Michael S. Saag · University Of Alabama At Birmingham$85,103,222
- Constance Ann Benson · University Of California, San Diego$66,071,396
- Mark Marino · Venturewell$61,796,923
Research focus
Point Of CareTuberculosisScreeningIncidenceC-Reactive ProteinClinicSymptomsFutureCharacteristicsLifeScale UpUnited States National Institutes Of HealthInterleukin-6SpecificityInfectionAcute-Phase ProteinsUgandaMediatingPreventAntiretroviral TherapyBlood CapillariesCost EffectiveCost EffectivenessEpidemic
Grant awards (15)
Optimal tuberculosis screening and tuberculosis preventive therapy delivery strategies to improve maternal and birth outcomes among pregnant women with HIV in Uganda: a randomized trial$853,975
R61 · FY2025 · HL · contact PI
Optimal tuberculosis screening and tuberculosis preventive therapy delivery strategies to improve maternal and birth outcomes among pregnant women with HIV in Uganda: a randomized trial$411,682
R61 · FY2025 · HL · contact PI
Point-of-care C-reactive protein-based tuberculosis screening in people living with HIV: a randomized trial$711,595
R33 · FY2024 · HL · contact PI
Point-of-care C-reactive protein-based tuberculosis screening in people living with HIV: a randomized trial$1,056,953
R33 · FY2023 · HL · contact PI
Point-of-care C-reactive protein-based tuberculosis screening in people living with HIV: a randomized trial$1,060,388
R33 · FY2022 · HL · contact PI
Point-of-care C-reactive protein-based tuberculosis screening in people living with HIV: a randomized trial$960,438
R33 · FY2021 · HL · contact PI
Improving the efficiency of clinic-based active tuberculosis case finding: evaluation of point-of-care C-reactive protein-based triage testing in Vietnam.$204,886
R21 · FY2021 · AI · contact PI
Improving the efficiency of clinic-based active tuberculosis case finding: evaluation of point-of-care C-reactive protein-based triage testing in Vietnam.$181,824
R21 · FY2020 · AI · contact PI
Point-of-care C-reactive protein-based tuberculosis screening in people living with HIV: a randomized trial$963,941
R61 · FY2019 · HL · contact PI
Evaluation of novel tuberculosis screening strategies for people living with HIV$197,640
K23 · FY2018 · AI · contact PI
Point-of-care C-reactive protein-based tuberculosis screening among people living with HIV: planning a comparative effectiveness trial$235,938
R34 · FY2017 · AI · contact PI
Evaluation of novel tuberculosis screening strategies for people living with HIV$197,640
K23 · FY2017 · AI · contact PI
Evaluation of novel tuberculosis screening strategies for people living with HIV$183,276
K23 · FY2016 · AI · contact PI
Evaluation of novel tuberculosis screening strategies for people living with HIV$181,867
K23 · FY2015 · AI · contact PI
Evaluation of novel tuberculosis screening strategies for people living with HIV$182,805
K23 · FY2014 · AI · contact PI